GC Genome Corporation (KOSDAQ:340450)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,000.00
-120.00 (-1.32%)
Jul 18, 2025, 3:30 PM KST

GC Genome Revenue

GC Genome had revenue of 6.81B KRW in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 26.95B. In the year 2024, GC Genome had annual revenue of 25.89B, down -5.15%.

Revenue (ttm)
26.95B
Revenue Growth
-5.15%
P/S Ratio
7.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
212.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202425.89B-1.40B-5.15%
Dec 31, 202327.29B3.18B13.18%
Dec 31, 202224.11B5.62B30.36%
Dec 31, 202118.50B4.94B36.46%
Dec 31, 202013.56B1.40B11.51%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
HLB Co., Ltd.74.64B
Peptron4.30B
PharmaResearch392.31B
Revenue Rankings